Novartis will apply Generate:Biomedicines’ generative artificial intelligence (AI) platform to discover and develop protein therapeutics for multiple unspecified disease areas, through a collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback